| (USD) | Dec 2023 | Y/Y change |
|---|---|---|
| Revenue | 483.98K | — |
| Operating expense | — | — |
| Net income | -152.34K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, APLIF returned -30.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -40.0% |
| 1 year | -30.8% |
| 5 years | -98.4% |
| All-time high | $0.99 (Apr 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in APLIF would be worth today ›No. Appili Therapeutics Inc. has not paid a dividend in the past 12 months.
Appili Therapeutics Inc. is part of the Healthcare sector.
Appili Therapeutics Inc. has a market cap of 1.31M USD, based on the latest quote.
Appili Therapeutics Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
